References

Carroll CL, Huntington PJ. Body condition scoring and weight estimation of horses. Equine Vet J. 1988; 20:(1)41-45 https://doi.org/10.1111/j.2042-3306.1988.tb01451.x

Frape D. Equine Nutrition and Feeding.: John Wiley and Sons; 2004

Graham-Thiers PM, Kronfeld DS. Amino acid supplementation improves muscle mass in aged and young horses. J Anim Sci. 2005; 83:(12)2783-2788 https://doi.org/10.2527/2005.83122783x

Jensen M, Lindholm A, Hakkarainen J. The vitamin E distribution in serum, liver, adipose and muscle tissues in the pig during depletion and repletion. Acta Vet Scand. 1990; 31:(2)129-136 https://doi.org/10.1186/BF03547553

Harris P, Geor RJ, Coenen M. Controversial areas in equine nutrition and feeding management: the editors' views.Amsterdam, The Netherlands: Elsevier; 2013

Harris PA, Ellis AD, Fradinho MJ Review: Feeding conserved forage to horses: recent advances and recommendations. Animal. 2017; 11:(6)958-967 https://doi.org/10.1017/S1751731116002469

McCue ME, Valberg SJ, Miller MB Glycogen synthase (GYS1) mutation causes a novel skeletal muscle glycogenosis. Genomics. 2008; 91:(5)458-466 https://doi.org/10.1016/j.ygeno.2008.01.011

McCue ME, Armién AG, Lucio M, Mickelson JR, Valberg SJ. Comparative skeletal muscle histopathologic and ultrastructural features in two forms of polysaccharide storage myopathy in horses. Vet Pathol. 2009; 46:(6)1281-1291 https://doi.org/10.1354/vp.08-VP-0177-M-FL

Naylor RJ, Livesey L, Schumacher J Allele copy number and underlying pathology are associated with subclinical severity in equine type 1 polysaccharide storage myopathy (PSSM1). PLoS One. 2012; 7:(7) https://doi.org/10.1371/journal.pone.0042317

Powers SK, Jackson MJ. Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiol Rev. 2008; 88:(4)1243-1276 https://doi.org/10.1152/physrev.00031.2007

Schwarz B, Ertl R, Zimmer S Estimated prevalence of the GYS-1 mutation in healthy Austrian Haflingers. Vet Rec. 2011; 169:(22) https://doi.org/10.1136/vr.d5438

Polysaccharide Storage Myopathy (PSSM) Disease. 2017. https://www.myhorseuniversity.com/single-post/pssm-disease (accessed 5 July 2023)

Valberg SJ. Muscle conditions affecting sport horses. Vet Clin North Am Equine Pract. 2018; 34:(2)253-276 https://doi.org/10.1016/j.cveq.2018.04.004

Diagnosis and Management of Myofibrillar Myopathy in Warmblood Performance Horses. 2021. https://aaep.org/sites/default/files/2022-05/Valberg,%20Stephanie.pdf (accessed 5 July 2023)

Valberg SJ, Cardinet GH, Carlson GP, DiMauro S. Polysaccharide storage myopathy associated with recurrent exertional rhabdomyolysis in horses. Neuromuscul Disord. 1992; 2:(5-6)351-359 https://doi.org/10.1016/s0960-8966(06)80006-4

Valberg SJ, Macleay JM, Billstrom JA, Hower-Moritz MA, Mickelson JR. Skeletal muscle metabolic response to exercise in horses with ‘tying-up’ due to polysaccharide storage myopathy. Equine Vet J. 1999; 31:(1)43-47 https://doi.org/10.1111/j.2042-3306.1999.tb03789.x

Valberg SJ, McKenzie EC, Eyrich LV, Shivers J, Barnes NE, Finno CJ. Suspected myofibrillar myopathy in Arabian horses with a history of exertional rhabdomyolysis. Equine Vet J. 2016; 48:(5)548-556 https://doi.org/10.1111/evj.12493

Valberg SJ, Nicholson AM, Lewis SS, Reardon RA, Finno CJ. Clinical and histopathological features of myofibrillar myopathy in Warmblood horses. Equine Vet J. 2017; 49:(6)739-745 https://doi.org/10.1111/evj.12702

Valberg SJ, Perumbakkam S, McKenzie EC, Finno CJ. Proteome and transcriptome profiling of equine myofibrillar myopathy identifies diminished peroxiredoxin 6 and altered cysteine metabolic pathways. Physiol Genomics. 2018; 50:(12)1036-1050 https://doi.org/10.1152/physiolgenomics.00044.2018

Valberg SJ, Williams ZJ, Finno CJ Type 2 polysaccharide storage myopathy in Quarter Horses is a novel glycogen storage disease causing exertional rhabdomyolysis. Equine Vet J. 2023; 55:(4)618-631 https://doi.org/10.1111/evj.13876

Valentine BA, Van Saun RJ, Thompson KN, Hintz HF. Role of dietary carbohydrate and fat in horses with equine polysaccharide storage myopathy. J Am Vet Med Assoc. 2001; 219:(11)1537-1544 https://doi.org/10.2460/javma.2001.219.1537

Valentine BA. Equine polysaccharide storage myopathy. Equ Vet Edu. 2003; 15:254-262

Williams ZJ, Bertels M, Valberg SJ. Muscle glycogen concentrations and response to diet and exercise regimes in Warmblood horses with type 2 Polysaccharide Storage Myopathy. PLoS One. 2018; 13:(9) https://doi.org/10.1371/journal.pone.0203467

Williams ZJ, Velez-Irizarry D, Gardner K, Valberg SJ. Integrated proteomic and transcriptomic profiling identifies aberrant gene and protein expression in the sarcomere, mitochondrial complex I, and the extracellular matrix in Warmblood horses with myofibrillar myopathy. BMC Genomics. 2021; 22:(1) https://doi.org/10.1186/s12864-021-07758-0

A nutritional review of polysaccharide storage myopathy

02 July 2023
8 mins read
Volume 7 · Issue 4

Abstract

Polysaccharide storage myopathy is characterised as the dissolution of skeletal muscle in association with exercise. Genetic testing has uncovered two forms of polysaccharide storage myopathy: PSSM1 and PSSM2, and a subtype known as myofibrillar myopathy. Horses with these conditions can display a variety of symptoms. Nutritional management of PSSM1 and PSSM2 cases hinges on ensuring that rations are low in both starch and sugar, and daily exercise is also important for these horses.

Polysaccharide storage myopathy (PSSM) is also referred to as ‘tying up’, azoturia, Monday morning disease or exertional rhabdomyolysis syndrome (Frape, 2004). In simple terms, it is characterised as the dissolution of skeletal muscle in association with exercise. The term ‘polysaccharide’ refers to complex sugars stored in skeletal muscle.

Genetic testing now distinguishes two forms of PSSM and, more recently, a sub-type:

PSSM1 is caused by a genetic mutation in the glycogen synthase gene – glycogen is the storage form of starch and sugar. PSSM2 represents one, or more, other form of muscle disease that is characterised by abnormal staining of muscle glycogen in microscopic examination of muscle biopsies, while myofibrillar myopathy is described as an abnormal build-up of ‘desmin’ (a protein) in muscle tissue and myofibrillar degeneration (Valberg et al, 2017).

Type 1 PSSM was first described in detail by Valberg et al (1992) and is associated with a dominant mutation in the skeletal muscle glycogen synthase gene (GYS1). This gene mutation causes excessive storage of sugar (glycogen) in skeletal muscle (Valberg, 2017).

Register now to continue reading

Thank you for visiting UK-VET Equine and reading some of our peer-reviewed content for veterinary professionals. To continue reading this article, please register today.